Search
Psychedelic Experience
A look inside Mindstate Design Labs' effort to design drugs that reliably produce specific states of mind.
A powerful psychedelic long used in African rituals shows surprising promise for treating traumatic brain injury and PTSD.
MAPS founder Rick Doblin speaks to Big Think about the FDA’s rejection of MDMA therapy and the future of psychedelic treatments.
A recent study suggests that exposure to visual stimuli can diminish the effects of psychedelic drugs.
The heart's rhythms may play a larger role in shaping psychedelic experiences than previously thought.
In a psychedelic state, the relationship between your “narrative” and “minimal” selves seems to transform in unique ways.
Why does the DMT experience feel so familiar to some people — even those who are trying the psychedelic for the first time?
Neuroscientists and artists alike are making the case that we could transform the world through psychedelics.
Psychedelics mess with our prior beliefs, and could help us see what forms these beliefs in the first place.
End of life patients face mental health challenges uniquely existential and spiritual in nature — but psychedelics are emerging as a possible solution to relieve the suffering.
New research shows psychedelics activate receptors inside brain cells that other compounds, like serotonin, cannot.
Antidepressants can help alleviate PTSD symptoms when paired with psychotherapy, but does our overenthusiasm for them blind us to more effective alternatives?
A key question is how to keep that relief going without relying solely on repeated ketamine infusions.
Fluphenazine, once used to treat schizophrenia, is capable of blocking a compound connected to chronic pain.
A toxicological study shows that the victims of human sacrifice consumed coca leaves and ayahuasca before they were killed, but not for reasons we originally thought.